Clin2
NCT05995769Possibly a fitRecruiting

Psilocybin therapy with talk therapy for alcohol problems

Alcohol Use DisorderAlcoholism

Treatments studied

Part of Mental health clinical trials.

This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
128 people
Ages
22 years to 65 years
Study type
Interventional

Who can take part

  • You must have at least moderate alcohol use disorder, based on standard criteria.
  • You need to have had heavy drinking days and a certain number of drinks in the last month.
  • You must want to cut down on your drinking.
  • You should have used hallucinogens (like LSD or psilocybin) only a few times or not at all.
  • You cannot have a serious problem with other drugs (except nicotine) in the last 6 months, or a history of psychosis or bipolar disorder, or recent suicidal thoughts.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06444243Not yet recruiting· Phase 2
Psilocybin therapy for alcohol use disorder

This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.

NCT07296094Not yet recruiting· Phase 2
Psilocybin therapy for severe alcohol use disorder

This trial tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help people with severe alcohol use disorder reduce or stop drinking. It's for people who've recently completed detox and are ready to commit to a structured program in Boston.

Boston, Massachusetts
NCT06349083Recruiting· Phase 2
Psilocybin-assisted treatment for alcohol use disorder

This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.

New York, New York
NCT07638553Recruiting· Phase 3
Psilocybin to prevent alcohol relapse with depression

This study tests whether psilocybin (a psychedelic compound) can help people with severe alcohol use disorder stay sober longer, especially if they also have depression. Participants receive guided psilocybin sessions alongside counseling to reduce the risk of returning to heavy drinking.

Bayonne
NCT06405607Recruiting· Phase 2
Psilocybin vs Ketamine for Alcohol Use Disorder Trial

This trial tests two psychedelic-assisted therapies, psilocybin and ketamine, to see which works better for reducing heavy drinking in people with alcohol use disorder (AUD). You'll receive either drug along with counseling, and the study monitors safety closely.

Iowa City, Iowa
NCT06885996Not yet recruiting· Phase 2
Psilocybin therapy for PTSD from partner violence

This trial tests whether psilocybin, a substance that can help the brain process trauma, combined with therapy can reduce PTSD symptoms in people who have experienced intimate partner violence. You must be at least 6 months past the last incident and not have serious health or mental health issues.

Calgary, Alberta

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.